Efficacy and tolerability of entacapone in patients with Parkinson's disease treated with levodopa plus a dopamine agonist and experiencing wearing-off motor fluctuations. A randomized, double-blind, multicentre study.
about
Evaluation of the efficacy and safety of adjuvant treatment to levodopa therapy in Parkinson´s disease patients with motor complicationsHealth-related quality of life as an outcome variable in Parkinson's disease.Current status of symptomatic medical therapy in Parkinson's diseaseEvidence-based efficacy comparison of tolcapone and entacapone as adjunctive therapy in Parkinson's disease.One-year open-label study of entacapone in patients with advanced Parkinson disease.Meta-analysis of the comparative efficacy and safety of adjuvant treatment to levodopa in later Parkinson's disease.Rotigotine transdermal patch for the treatment of Parkinson's Disease.Pharmacological strategies for the management of levodopa-induced dyskinesia in patients with Parkinson's disease.Therapeutic interventions and adjustments in the management of Parkinson disease: role of combined carbidopa/levodopa/entacapone (Stalevo).Use of catechol-O-methyltransferase inhibition to minimize L-3,4-dihydroxyphenylalanine-induced dyskinesia in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaque.[Olanzapine use in cancer patients for refractory vomiting].Adverse effects produced by different drugs used in the treatment of Parkinson's disease: A mixed treatment comparison.Efficacy and Safety of Adjuvant Treatment with Entacapone in Advanced Parkinson's Disease with Motor Fluctuation: A Systematic Meta-Analysis.
P2860
Q24234273-0B8E9A85-4A6C-4514-A915-300BB5F7F39AQ35825918-243ACBF0-6CC5-4A09-BB5B-92FD7DB2EF48Q37131229-B930AED0-5633-4847-A748-CA7D28AEA538Q37164701-A3371AB9-3839-4F3C-82B4-732356F8C239Q37203293-C2A07E38-C090-46C8-A308-9FF283B28025Q37849251-B6D5BC57-9292-4D76-87DA-C4A02CAFF05DQ37982789-0D64B453-E133-4F73-9478-730A0A563A3DQ38262418-642BAB6E-F7E3-446A-9E6B-9F1F39DE7889Q42427666-8DDCD16A-6E0A-45E9-839F-0ADB5ADF2894Q45075694-1C980BA3-4E70-4582-8F22-23D907DB61DDQ46986949-A760B26D-9988-4D0B-85A6-72AB4B5AB030Q48129862-26FD3DF6-FE7A-4E91-9DF9-EE140A591DDCQ50502365-D9830DBC-A6F6-4A11-AD1E-FCB5D636D95E
P2860
Efficacy and tolerability of entacapone in patients with Parkinson's disease treated with levodopa plus a dopamine agonist and experiencing wearing-off motor fluctuations. A randomized, double-blind, multicentre study.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Efficacy and tolerability of e ...... uble-blind, multicentre study.
@en
Efficacy and tolerability of e ...... uble-blind, multicentre study.
@nl
type
label
Efficacy and tolerability of e ...... uble-blind, multicentre study.
@en
Efficacy and tolerability of e ...... uble-blind, multicentre study.
@nl
prefLabel
Efficacy and tolerability of e ...... uble-blind, multicentre study.
@en
Efficacy and tolerability of e ...... uble-blind, multicentre study.
@nl
P2093
P1476
Efficacy and tolerability of e ...... uble-blind, multicentre study.
@en
P2093
I Bourdeix
J L Montastruc
J Schadrack
S Giménez-Roldán
P2888
P304
P356
10.1007/S00702-002-0799-Z
P577
2003-03-01T00:00:00Z